1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBoston Scientific Foundation Health Grant is sponsored by Boston Scientific Foundation. Supports research related to non-communicable diseases, including cancer, targeting economically disadvantaged populations in specific U.S. locations.
Get alerted about grants like this
Get emailed when new opportunities from “Boston Scientific Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Nonprofit organizations serving economically disadvantaged populations in California, Indiana, Massachusetts, Minnesota, or Puerto Rico. Confirm the full requirements in the official notice before applying.
The current listing shows $10,000 - $30,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Boston Scientific Foundation Health Grant is funded by Boston Scientific Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Massachusetts, California, Minnesota, and Indiana. Check the official notice for exact location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The Cummings Foundation will give away $30 million to 150 Greater Boston nonprofits in the 2026 cycle — 125 three-year grants and 25 ten-year grants, at $10K–$100K a year. The letter of inquiry opens July 15 and closes September 17. Here's how the geography rules actually work, why the ten-year track rewards past winners, and how to write an LOI that survives a jury of community volunteers.
Read articleAmerica's Seed Fund powered by NSF reopened for FY2026 with two parallel solicitations: NSF 26-510 for deep technologies and a new pilot, NSF 26-511, dedicated to scientific instrumentation. Project Pitch is the mandatory first gate, the first full-proposal deadline is July 27, 2026, and Phase I runs up to $305K. Here is how the topic-agnostic NSF model differs from agency-directed SBIR — and how to use the new pilot.
Read articleNSF restarted its SBIR/STTR programs on May 31, 2026 after a multi-month hiatus, with a $250 million FY26 allocation, a Project Pitch portal reopen on June 2, and a first full-proposal deadline of July 27, 2026. The big structural changes: a new Strategic Breakthrough tier that extends invited Phase II companies up to $30 million, and a $40 million pilot for next-generation scientific instrumentation. Phase I tops out at $305K, Phase II at $1.25M, with November 4 and March 4, 2027 windows behind the July 27 first deadline. For deep-tech startups that watched the NIH SBIR omnibus go dark and DARPA pull back on conventional Phase II slots, this is the most consequential reopening of the year — and the Strategic Breakthrough tier is the first time NSF has competed directly with venture capital at growth-stage check sizes.
Read article